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background: Compromised right ventricular function as defined by depressed right ventricular stroke work index (RVSWI) increases morbidity after 
cardiac surgery. The prevalence and impact of preoperative RVSWI on morbidity and mortality after transcatheter aortic valve replacement (TAVR) is 
unknown.
Methods: We compared post-procedural morbidity and 1-year mortality among 196 consecutive patients undergoing TAVR at a single center 
from 4/2009 - 4/2013 with RVSWI < 450 mmHg*ml/m2 to those with normal RVSWI. Post-procedural morbidity was evaluated by: duration of 
intubation, ICU and hospital length of stay. Subgroup analysis was limited to those with concurrent pulmonary hypertension (PH), defined by mean 
pulmonary artery pressure < 25 mmHg.
results: 146 patients had sufficient data to calculate RVSWI (age 86 ±9, female 55 %, transfemoral access 61%, left ventricular ejection fraction 
50 ±14%, PH 66%) with a mean follow up of 1.1 ± 0.8 years. Baseline characteristics were similar between groups, including severity of mitral 
regurgitation. The prevalence of RVSWI < 450 was 23% overall: 14% in those with PH, 41% in those without PH (p < 0.001). There was no statistically 
significant difference in intubation time, ICU or hospital length of stay, or 1-year mortality between RVSWI groups regardless of the presence of PH 
(p= NS for all, Table).
conclusion: Depressed RVSWI is common among patients undergoing TAVR, but does not impact post-procedural morbidity or 1-year mortality in 
patients undergoing TAVR.
